Status:
WITHDRAWN
Performance and Safety Evaluation of a Novel Non-invasive Glucose Monitoring Device
Lead Sponsor:
RSP Systems A/S
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This pivotal multicenter study has been launched to collect spectral Raman data paired with validated glucose reference values in diabetic patients.
Detailed Description
Participants will be enrolled at six different sites in four different countries. All participants will undergo identical procedures, which include four steps: Baseline visit (1 day), calibration peri...
Eligibility Criteria
Inclusion
- Male and female subjects ≥18 years of age
- Diagnosed with diabetes, all types except gestational diabetes
- Skin phototype 1-4
- Willing to perform a minimum of 8 finger sticks during each day of home-based measurements and 30 finger sticks at the two in-clinic study days
- Subject has a wireless internet connection at home to be used in the study
Exclusion
- For female subjects: Pregnancy or subject is attempting to conceive or not willing and able to practice birth control during the study duration
- For female subjects: Breastfeeding
- Subject currently participating in another study
- Subject not able to understand and read the local language
- In investigator's opinion, subject is not able to follow instructions provided and as specified in the protocol
- Subject not able to hold hand/arm steady (including tremors and Parkinson's Disease)
- Subject diagnosed with cardiovascular diseases
- Reduced circulation in right hand evaluated by Allen's test
- Subjects receiving anticoagulants, active cancer treatment, tetracyclines and other medication/topical agents increasing photosensitivity
- Radiotherapy for the past six months
- Extensive skin changes, tattoos or diseases on right hand thenar (probe application site)
- Known allergy to medical grade alcohol used to clean the skin
- Medical history or any condition that may, in the opinion of the investigator compromise the subject's ability to participate
- Comorbidity or concomitant medical condition which, in the opinion of the Investigator, could interfere with the study or present a risk to the safety or welfare of the subject or study staff
Key Trial Info
Start Date :
June 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04031300
Start Date
June 1 2019
End Date
June 1 2019
Last Update
November 21 2023
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Steno Diabetes Center Copenhagen (SDCC)
Gentofte Municipality, Denmark, 2820
2
Steno Diabetes Center Odense (SDCO)
Odense C, Denmark, 5000
3
Institut für Diabetes-Technologie Forschungs- und Entwicklungs-gesellschaft mbH an der Universität Ulm (IDT)
Ulm, Germany, 89081
4
Sahlgrenske University Hospital (SUH)
Gothenburg, Sweden, 413 45